Cargando…

Prevalence of Psychotropic Polypharmacy and Associated Healthcare Resource Utilization during Initial Phase of Care among Adults with Cancer in USA

BACKGROUND: The use of psychotropic medications is not uncommon among patients with newly diagnosed cancer. However, the impact of psychotropic polypharmacy on healthcare utilization during the initial phase of cancer care is largely unknown. METHODS: We used a claims database to identify adults wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aroke, Hilary A., Vyas, Ami M., Buchanan, Ashley L., Kogut, Stephen J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520416/ https://www.ncbi.nlm.nih.gov/pubmed/31020617 http://dx.doi.org/10.1007/s40801-019-0153-5

Ejemplares similares

Estimating the Direct Costs of Outpatient Opioid Prescriptions: A Retrospective Analysis of Data from the Rhode Island Prescription Drug Monitoring Program
por: Aroke, Hilary, et al.
Publicado: (2018)

Chronic Condition Clusters and Polypharmacy among Adults
por: Vyas, Ami, et al.
Publicado: (2012)

Prolonged neuropsychiatric effects following management of chloroquine intoxication with psychotropic polypharmacy
por: Maxwell, Nicole M, et al.
Publicado: (2015)

Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and Commentary
por: Zito, Julie M., et al.
Publicado: (2021)

Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015
por: Lohr, W. David, et al.
Publicado: (2018)

A bitter pill to swallow - Polypharmacy and psychotropic treatment in people with advanced dementia
por: Riedl, Lina, et al.
Publicado: (2022)

Obesity and healthcare resource utilization: comparative results from the UK and the USA
por: Nørtoft, E., et al.
Publicado: (2017)

Polypharmacy-induced cognitive dysfunction and discontinuation of psychotropic medication: a neuropsychological case report
por: Valtonen, Jussi, et al.
Publicado: (2020)

Correlates of Psychotropic Polypharmacy in outpatient psychiatric clinics of two military tertiary hospitals in Saudi Arabia
por: Alharbi, Fares F., et al.
Publicado: (2019)

High-level psychotropic polypharmacy: a retrospective comparison of children in foster care to their peers on Medicaid
por: Davis, Deborah Winders, et al.
Publicado: (2021)

Ten-Year Trends in Psychotropic Prescribing and Polypharmacy in Australian General Practice Patients with and without Dementia
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2023)

Healthcare Resource Utilization and Costs Following Diagnosis of Nontuberculous Mycobacterial Lung Disease in the USA
por: Marras, Theodore, et al.
Publicado: (2017)

Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study
por: McKeigue, Paul M., et al.
Publicado: (2021)

Clinical Utility of Medication-Based Risk Scores to Reduce Polypharmacy and Potentially Avoidable Healthcare Utilization
por: Silva-Almodóvar, Armando, et al.
Publicado: (2022)

Healthcare resource availability and cardiovascular health in the USA
por: Pilkerton, Courtney S, et al.
Publicado: (2017)

Impact of the COVID-19 pandemic on healthcare resource utilization across selected disease areas in the USA
por: Engelbrecht, Kayla, et al.
Publicado: (2022)

PHARMACY DEDUCTIBLES CAN COMPLICATE THE RELATIONSHIP BETWEEN MEASURES OF PATIENT COST SHARING AND MEDICATION ADHERENCE
por: Kogut, Stephen J, et al.
Publicado: (2023)

Psychotropic Polypharmacy in Adults 55 Years or Older: A Risk for Impaired Global Cognition, Executive Function, and Mobility
por: Loggia, Gilles, et al.
Publicado: (2020)

A delicate balance: Psychotropic polypharmacy and anti‐cholinergic use are correlated with fall incidence in Australian inpatients with dementia
por: Tan, Samuel X., et al.
Publicado: (2021)

Effects of medical service fee revision on reducing irrational psychotropic polypharmacy in Japan: an interrupted time-series analysis
por: Okada, Yusuke, et al.
Publicado: (2021)

Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA
por: Laliberté, François, et al.
Publicado: (2020)

Effect of Pharmacist Intervention on a Population in Taiwan with High Healthcare Utilization and Excessive Polypharmacy
por: Wang, Tzu-Chueh, et al.
Publicado: (2019)

Psychotropic Drug Utilization Pattern among Schizophrenics
por: Dutta, Shakti Bala, et al.
Publicado: (2004)

Psychotropic drugs and driving: prevalence and types
por: Alonso, Francisco, et al.
Publicado: (2014)

The effect of polypharmacy on healthcare services utilization in older adults with comorbidities: a retrospective cohort study
por: Doumat, George, et al.
Publicado: (2023)

Prevalence of polypharmacy and associated adverse outcomes and risk factors among children with asthma in the USA: a cross-sectional study
por: Xie, Luyu, et al.
Publicado: (2022)

Patient factors associated with the use of psychotropic polypharmacy in patients under the care of a community mental health team in the West of Ireland
por: Srikumar, Karthika, et al.
Publicado: (2021)

Psychotropic drug utilization pattern among patients with schizophrenia
por: Dutta, Shakti Bala, et al.
Publicado: (2005)

Utilization of psychotropic medicines in Romania during 1998–2018
por: Iaru, Irina, et al.
Publicado: (2023)

Healthcare Resource Use and Costs Associated with Opioid Initiation Among Patients with Newly Diagnosed Endometriosis with Commercial Insurance in the USA
por: Estes, Stephanie J., et al.
Publicado: (2020)

A 12-Year Retrospective Study of the Prevalence of Anticholinergic Polypharmacy and Associated Outcomes Among Medicare Patients with Overactive Bladder in the USA
por: Campbell, Noll L., et al.
Publicado: (2021)

The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization
por: Schwarting, Andreas, et al.
Publicado: (2021)

Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs
por: Surrey, Eric, et al.
Publicado: (2020)

Changes in psychotropic polypharmacy and high‐potency prescription following policy change: Findings from a large scale Japanese claims database
por: Takeshima, Masahiro, et al.
Publicado: (2022)

Child Tobacco Smoke Exposure and Healthcare Resource Utilization Patterns
por: Merianos, Ashley L., et al.
Publicado: (2020)

Retrospective observational study of asthma and chronic obstructive pulmonary disease prevalence and associated healthcare resource utilization in a large, integrated healthcare system
por: Collinsworth, Ashley W., et al.
Publicado: (2022)

Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA
por: Olson, Amy L., et al.
Publicado: (2020)

Utilization of psychotropic medications in children with FASD: a retrospective review
por: Durr, Michael-Roy R., et al.
Publicado: (2021)

Trends in the utilization of psychotropic medications in China from 2018 to 2021
por: Zhang, Xinyan, et al.
Publicado: (2022)

Clinical initiatives linking Japanese and Swedish healthcare resources on cancer studies utilizing Biobank Repositories
por: Nishimura, Toshihide, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b3idscsvnti06k6p4d4pi3lg7k